HEC169096 in Participants With Advanced Solid Tumors

Clinical trial NCT05451602 · RECRUITING

Trial details

NCT number: NCT05451602
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-10-21
Primary completion: 2026-12-30
Enrollment: 456

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.